Clinical Trial

A Long Term Follow-up Study of TScan TCR-T Products

Study acronym: LTFU
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2025-09-02
Trial Details
NCT Number NCT06976736
Lead Sponsor TScan Therapeutics, Inc.
Conditions AML, ALL, MDS
Enrollment 1,000 participants
Start Date 2025-09-09
Primary Completion 2040-09 (estimated)
Study Completion 2040-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-10